Marco Zarbin

Summary

Country: USA

Publications

  1. doi request reprint Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis
    Marco A Zarbin
    Institute of Ophthalmology and Visual Science, New Jersey Medical School, Newark, New Jersey 07103, USA
    Ophthalmology 120:1432-9. 2013

Detail Information

Publications1

  1. doi request reprint Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis
    Marco A Zarbin
    Institute of Ophthalmology and Visual Science, New Jersey Medical School, Newark, New Jersey 07103, USA
    Ophthalmology 120:1432-9. 2013
    ..To report outcomes of ophthalmic evaluations in clinical studies of patients receiving fingolimod (Gilenya; Novartis Pharma AG, Basel, Switzerland) for multiple sclerosis (MS)...